AstraZenca Pharma India Ltd. | ASTRAZEN | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|
Cash and cash equiva... |
| 1,259 | 1,733 | 2,525 | 3,524 |
Short-term investment |
| 0 | 0 | 0 | 0 |
Accounts receivables |
| 546 | 798 | 832 | 852 |
Inventories |
| 1,132 | 1,181 | 1,652 | 1,598 |
Deferred income taxes |
| 0 | 0 | 0 | 0 |
Other current assets |
| 272 | 336 | 414 | 214 |
Total current assets |
| 3,209 | 4,047 | 5,423 | 6,188 |
Gross property plant... |
| 755 | 748 | 603 | 699 |
Accumulated Depriciat... |
| 0 | 0 | 0 | 0 |
Net property, plant and Eq... |
| 755 | 748 | 603 | 699 |
Work in Progress |
| 36 | 69 | 242 | 40 |
Miscellaneous Investment |
| 26 | 29 | 39 | 43 |
Deferred income taxes |
| 561 | 698 | 635 | 646 |
Intangible assets |
| 0 | 0 | 0 | 0 |
Goodwill |
| 0 | 0 | 0 | 0 |
Other long-term assets |
| 18 | 27 | 122 | 131 |
Total non-current assets |
| 1,396 | 1,571 | 1,640 | 1,560 |
Total assets |
| 4,605 | 5,618 | 7,064 | 7,747 |
Short-term debt |
| 0 | 0 | 0 | 0 |
Accounts Payable... |
| 953 | 1,682 | 2,097 | 1,784 |
Provisions |
| 350 | 346 | 444 | 369 |
Taxes Payable |
| 54 | 18 | 21 | 56 |
Deferred Revenues |
| 0 | 0 | 0 | 0 |
Capital Leases |
| 0 | 0 | 25 | 35 |
Other current liabilities |
| 713 | 544 | 685 | 791 |
Total current liabilities |
| 2,070 | 2,590 | 3,272 | 3,035 |
Long-term debt |
| 0 | 0 | 0 | 0 |
Investments Liabilities |
| 0 | 0 | 0 | 0 |
Deferred tax liabilities |
| 0 | 0 | 0 | 0 |
Provisions |
| 67 | 20 | 54 | 64 |
Capital Leases |
| 0 | 0 | 93 | 86 |
Other longterm liabilities |
| 0 | 0 | 0 | 0 |
Total non-current liabilities |
| 67 | 20 | 147 | 150 |
Total liabilities |
| 2,136 | 2,610 | 3,419 | 3,185 |
Share Capital |
| 50 | 50 | 50 | 50 |
Share premium |
| 0 | 0 | 0 | 0 |
Retained earnings |
| 2,419 | 2,958 | 3,594 | 4,512 |
Accumulated other equity |
| 0 | 0 | 0 | 0 |
Preferred Stock |
| 0 | 0 | 0 | 0 |
Minority Interest |
| 0 | 0 | 0 | 0 |
Total Equity |
| 2,469 | 3,008 | 3,644 | 4,562 |
Total Liabilities and Equity |
| 4,605 | 5,618 | 7,064 | 7,747 |
Cash per Share |
| Upgrade | Upgrade | Upgrade | Upgrade |
Cash, Current Inv Per share |
| Upgrade | Upgrade | Upgrade | Upgrade |